https://www.globenewswire.com/news-release/2023/02/08/2604357/0/en/2022-Parainfluenza-Virus-Infection-Pipeline-Insights-Featuring-AlloVir-Ansun-Biopharma-and-Moderna-Therapeutics.html
0
0
2022 Parainfluenza Virus Infection Pipeline Insights: Featuring AlloVir, Ansun Biopharma and Moderna Therapeutics - GlobeNewswire
+ 120 more
2/8/23 at 6:18pm
Organization
GlobeNewswire
Authors
Research Markets
33 words
0
Comments
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Parainfluenza Virus Infection - Pipeline Insight, 2022" clinical trials has been added to ......
You are the first to view
Create an account or login to join the discussion